- Home
- OMH vs ADTX Comparison
OMH vs ADTX Comparison
Compare OMH & ADTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OMH
- ADTX
- Stock Information
- Founded
- OMH 2015
- ADTX 2017
- Country
- OMH Singapore
- ADTX United States
- Employees
- OMH N/A
- ADTX N/A
- Industry
- OMH Real Estate
- ADTX Biotechnology: Pharmaceutical Preparations
- Sector
- OMH Finance
- ADTX Health Care
- Exchange
- OMH Nasdaq
- ADTX Nasdaq
- Market Cap
- OMH 4.6M
- ADTX 5.3M
- IPO Year
- OMH 2023
- ADTX 2020
- Fundamental
- Price
- OMH $2.11
- ADTX $2.30
- Analyst Decision
- OMH Strong Buy
- ADTX
- Analyst Count
- OMH 1
- ADTX 0
- Target Price
- OMH $15.00
- ADTX N/A
- AVG Volume (30 Days)
- OMH 407.2K
- ADTX 589.6K
- Earning Date
- OMH 01-01-0001
- ADTX 05-19-2025
- Dividend Yield
- OMH N/A
- ADTX N/A
- EPS Growth
- OMH N/A
- ADTX N/A
- EPS
- OMH N/A
- ADTX N/A
- Revenue
- OMH $5,390,607.00
- ADTX $133,985.00
- Revenue This Year
- OMH $102.52
- ADTX $15,768.94
- Revenue Next Year
- OMH $37.92
- ADTX N/A
- P/E Ratio
- OMH N/A
- ADTX N/A
- Revenue Growth
- OMH 25.77
- ADTX N/A
- 52 Week Low
- OMH $0.25
- ADTX $2.04
- 52 Week High
- OMH $3.35
- ADTX $27,200.00
- Technical
- Relative Strength Index (RSI)
- OMH 49.97
- ADTX 30.46
- Support Level
- OMH $1.99
- ADTX $2.21
- Resistance Level
- OMH $3.77
- ADTX $2.39
- Average True Range (ATR)
- OMH 0.43
- ADTX 0.39
- MACD
- OMH -0.05
- ADTX 0.49
- Stochastic Oscillator
- OMH 19.81
- ADTX 11.11
About OMH Ohmyhome Limited
Ohmyhome Ltd is a data and technology-driven property technology company based in Singapore. Through its subsidiaries, it operates a one-stop-shop property platform that provides end-to-end property solutions and services for its customers, which comprises brokerage services and emerging and other services, such as home renovation and furnishing services, listing and research, mortgage referral, legal services, and insurance referral services. The company derives its revenues from two sources: revenue from brokerage services, Property Management Services, and revenue from emerging and other services.
About ADTX Aditxt Inc.
Aditxt Inc is a life sciences company that develops, builds, and grows innovations with a focus on monitoring and modulating the immune system. It develops products designed to induce tolerance to transplanted organs. Its portfolio consists of two programs Adimune and AditxtScore. It firm's immunosuppressive (anti-rejection) drugs have made possible life-saving organ transplantation procedures and blocking of unwanted immune responses in autoimmune diseases. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) ADI-100, which utilizes a novel approach that mimics the way bodies naturally induce tolerance to tissues.